{"id":664992,"date":"2026-05-26T00:01:12","date_gmt":"2026-05-26T00:01:12","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/664992\/"},"modified":"2026-05-26T00:01:12","modified_gmt":"2026-05-26T00:01:12","slug":"sizing-is-the-new-fault-line-economic-analysis","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/664992\/","title":{"rendered":"Sizing Is The New Fault Line – Economic Analysis"},"content":{"rendered":"

<\/p>\n

AC<\/p>\n

<\/p>\n

Ankura Consulting Group LLC<\/p>\n


\n <\/a><\/p>\n

More<\/p>\n


\n <\/p>\n


\n \"Ankura
\n <\/a><\/p>\n


\nAnkura Consulting Group, LLC is an independent global expert services and advisory firm that delivers services and end-to-end solutions to help clients at critical inflection points related to conflict, crisis, performance, risk, strategy, and transformation. Ankura has more than 2,000 professionals serving 3,000+ clients across 55 countries. Collaborative lateral thinking, hard-earned experience, and multidisciplinary capabilities drive results and Ankura is unrivalled in its ability to assist clients to Protect, Create, and Recover ValueTM. For more information, please visit, ankura.com. <\/p>\n

<\/p>\n


\n Ankura’s latest insights explore critical challenges facing modern organizations, from sophisticated cyber threats exploiting trusted software supply chains to the unexpected impact of GLP-1 medications on apparel industry sizing models. The collection examines how businesses can build operational resilience against disruption, strengthen fraud oversight in complex markets like China, and adapt to emerging technologies including AI-driven banking systems and ransomware tactics.
\n \n <\/p>\n


\n United States
\n Strategy \n <\/p>\n


\n To print this article, all you need is to be registered or login on Mondaq.com. \n <\/p>\n

Article Insights<\/p>\n

Keith Jelinek\u2019s articles from Ankura Consulting Group LLC are most popular:<\/p>\n


\n with readers working within the Aerospace & Defence industries <\/p>\n

Ankura Consulting Group LLC are most popular: <\/p>\n


\n within Antitrust\/Competition Law topic(s) <\/p>\n

Overview<\/p>\n

The apparel industry has navigated plenty of advancements and disruptions \u2014 fast fashion, e-commerce, the COVID-19 pandemic-era athleisure boom. But GIP and GLP-1 medications (collectively, \u201cGLP-1\u201d) represent something categorically different: a biological shift in the American body, happening at scale, faster than the industry\u2019s planning and size-curve systems were designed to accommodate.<\/p>\n

\"1791572a.jpg\"<\/p>\n

For the first time in decades, the obesity rate in the U.S. has declined, dropping from a peak of 39.9% in 2022 to 37% in 2025. Typical weight loss of 10%-20% of body weight equates to one-to-five clothing sizes (Bernstein, 2026). The implication is not a minor recalibration of size curves. It is a structural reset of the demand landscape.<\/p>\n

What is accelerating adoption faster than most brands have modeled is the rapid expansion of access. GLP-1 medications were historically limited to diabetic patients, keeping the covered user base narrow. That is now changing on multiple fronts simultaneously:<\/p>\n


\nIn 2021, at the height of the pandemic, Wegovy received the first weight loss indication from the FDA expanding the covered base of semaglutide users beyond Type II diabetic patients.
\nOral Wegovy launched in January 2026 with a temporary offer at $149-$299\/ month for qualifying patients, removing the \u201cneedle fright\u201d barrier with a pill form replacement. Eli Lilly followed soon after with Foundayo in April 2026, with prices starting around $149\/month for cash-pay customers.
\nBeginning in February 2026, several GLP-1 drugs became available through the direct-to-patient channel advertised via TrumpRx, potentially further reducing access barriers.
\nFrom July 1 to December 31, 2026, the CMS \u201cMedicare GLP-1 Bridge\u201d program will provide coverage for Wegovy for weight loss with a $50 monthly copayment, aimed at eligible Medicare Part D beneficiaries.
\nFDA approvals for new indications \u2014 obstructive sleep apnea (Zepbound in December 2024), cardiovascular disease (Wegovy in March 2024, Rybelsus oral pill in October 2025), and weight-related comorbidities\u2014 mean a far broader set of patients\u2019 insurance may now cover prescriptions. <\/p>\n

The demographic profile of GLP-1 users has undergone a fundamental shift. No longer confined to those with Type 2 diabetes or the ultra-wealthy paying out-of-pocket, these treatments have entered the mainstream \u201ccommercial\u201d workforce.<\/p>\n

In 2026, according to a study by the American Academy of Procedural Medicine (AAOPM) roughly 45% to 48% of large employers now include anti-obesity medications in their health plans\u2014nearly doubling the coverage rates seen in 2023. This expansion, coupled with the introduction of direct-to-consumer \u201cself-pay\u201d tiers as low as $299\/month, has bridged the gap between the low-income (Medicaid) and high-income populations, potentially making these drugs a staple of middle-class healthcare. The demographic change may also spill into their wardrobes.<\/p>\n

KEY FACTS<\/p>\n

Over 12% of U.S. adults have tried GLP-1 medication (Gallup, 2025).<\/p>\n

80% of GLP-1 users anticipate needing new clothing due to size changes (Circana, 2025).<\/p>\n

Sizing Is the New Fault Line<\/p>\n

Apparel brands have historically adjusted their size curves once a year \u2014 a rhythm built around slow-moving demographic trends. GLP-1 adoption is rendering that cadence obsolete. Industry analysts note that brands are now revising size mix models more often than they have before. The classic 1-2-2-1 ordering ratio (one part S-two parts M-two parts L-one part XL) is giving way to a 2-2-1-1 model. Brands that clung to their legacy ratios through 2024 are now facing the compounding pressure of overstocked large sizes and shortages of small sizes. Circana\u2019s September 2025 data confirms the shift is now national, with larger bra band sizes (over 42) and D cups losing market share to smaller sizes \u2014 intimate apparel is emerging as a leading indicator for broader assortment categories.<\/p>\n

\u201cOverstock in large sizes and stockouts in small sizes. Brands that do not update their size curves might pay for it in both directions.\u201d<\/p>\n

The financial consequences are already in earnings reports. A leading men\u2019s plus-size retailer reported a 6% year-over-year (YoY) sales decline and $29.6 million net loss in Q4 2025, attributing pressure to GLP-1 usage among approximately 25% of its customer base. A major women\u2019s plus-size retailer reported a 14% Q4 sales drop and closed 151 stores throughout 2025. One important nuance: Height does not change with weight loss. Tall women losing two or three sizes still need the same inseam and sleeve length \u2014 creating an underserved small-but-tall segment that most assortments do not yet accommodate.<\/p>\n

A Potential Margin Uptick Tailwind<\/p>\n

The size shift is not just a demand story \u2014 it is a margin story. Fabric usage increases approximately 4%-5% per size step, and fabric represents 50%-70% of garment production cost. Since virtually all mainstream brands hold retail prices constant across sizes, every consumer sizing down reduces cost of goods sold (COGS) while revenue stays flat.<\/p>\n

\"1791572b.jpg\"<\/p>\n

A one-step average size shift across a brand\u2019s mix reduces total COGS by 2.4%-3.5% \u2014 flowing directly to gross profit. For a $500 million COGS brand, which is $12-$17.5 million in annual margin expansion, moving operating profit by 100-200 basis points, without changing a single retail price. In an industry averaging 10%-15% net margins, a sustained 1%-2% COGS tailwind represents a 7%-20% improvement in bottom-line profitability. This is a structural edge hiding in plain sight for brands that plan ahead.<\/p>\n

\u201cA single size step down could add $12-$17.5 million to your bottom line \u2014 without changing a single price tag\u201d<\/p>\n

Who Is Winning<\/p>\n

The opportunity is not evenly distributed. GLP-1 users carry larger apparel baskets for one to three years as they overhaul their wardrobes, and 50% report shopping more often since starting the drugs. The categories best positioned to capture that spend:<\/p>\n

\"1791572c.jpg\"<\/p>\n

What To Watch<\/p>\n

Access Acceleration<\/p>\n

Lower price tiers for D2C self-pay, oral GLP-1 pills (which Medicare is purchasing at $245\/month through a demonstration program and the BALANCE model), and telehealth platforms growing 59% YoY are simultaneously collapsing cost and friction barriers. Research analysts at JP Morgan estimate that roughly 25 million Americans will be on a GLP-1 by 2030, up from 5 million in 2023. Brands planning 12-18 months ahead must model the 2027 consumer, not who their customer was in 2025 (CNBC, 2026)<\/p>\n

Inclusive Sizing: Do Not Overcorrect<\/p>\n

68%-72% of American women wear plus sizes, yet plus-size clothing is only 12%-18% of apparel revenue \u2014 chronically undersupplied before GLP-1. Pulling back aggressively risks alienating a still large segment. The answer is a more dynamic size curve, not a retreat from extended sizing.<\/p>\n

The Returns Spiral<\/p>\n

Consumers cycling through two to three sizes in 12-18 months buy multiple sizes and return what does not fit. Simultaneously, brands are sitting on growing large-size overstock while stocking out in small. Retailers without dynamic assortment planning face both problems at once.<\/p>\n

Clear and Informative Sizing Communication<\/p>\n

Consumers who have bought the same size for years may suddenly find themselves less certain about what fits. As bodies shift mid-cycle, clear fit guides, detailed size charts, and diverse model representation can go a long way toward reducing friction at the point of purchase.<\/p>\n

The Feel-Good Wardrobe Refresh<\/p>\n

For many GLP-1 users, meaningful weight loss may prompt an entirely new wardrobe \u2014 not just everyday basics, but body-contouring categories like swimwear, intimates, and underwear that need to fit precisely to feel right.<\/p>\n

The Strategic Imperative<\/p>\n

The brands that win in this environment will not be those that react fast to today\u2019s size data, they will be those that build planning systems sophisticated enough to anticipate where demand is heading. GLP-1 adoption is not slowing down, and the structural forces it has set in motion \u2014 shifting size curves, rising returns, identity-driven purchasing, and the athleisure surge \u2014 are compounding.<\/p>\n

\u201cThe question for every apparel executive is no longer whether GLP-1 will affect their business. It already is. The question is whether their assortment strategy reflects it.\u201d<\/p>\n

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.<\/p>\n

[View Source] <\/a><\/p>\n","protected":false},"excerpt":{"rendered":" AC Ankura Consulting Group LLC More Ankura Consulting Group, LLC…\n","protected":false},"author":2,"featured_media":134515,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[23,3,21,19,22,20,25,24],"class_list":["post-664992","post","type-post","status-publish","format-standard","has-post-thumbnail","category-united-states","tag-america","tag-news","tag-united-states","tag-united-states-of-america","tag-unitedstates","tag-unitedstatesofamerica","tag-us","tag-usa"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/664992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=664992"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/664992\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/134515"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=664992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=664992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=664992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}